TipRanks
Pharming Group (PHAR)
NASDAQ:PHAR
Want to see PHAR full AI Analyst Report?

Compare Pharming Group (PHAR) vs. Competitors

240 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$11.77
$695.42M
66.38
-37.07%
2 Buy
0 Hold
0 Sell
Moderate Buy
Trevi Therapeutics
$13.47
$1.95B
-39.02
32.46%
10 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$13.83
$1.29B
-8.87
-16.86%
9 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$377.37
$7.92B
-21.63
449.51%
14 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$5.72
$426.63M
-1.97
-58.18%
3 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.58
$582.22M
-3.18
-42.43%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
9.68
-4.99
-34.01%
TRVI
Trevi Therapeutics
13.18
3.63
38.01%
ORIC
Oric Pharmaceuticals
11.98
-2.14
-15.16%
PRAX
Praxis Precision Medicines
280.14
228.10
438.32%
SPRY
ARS Pharmaceuticals
4.30
-6.04
-58.42%
PRME
Prime Medicine, Inc.
3.50
-2.37
-40.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts